Sun Pharma chief expects Ranbaxy deal to be closed by mid-Feb
Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of health regulators.
Jan 25, 2015, 11:14 AM IST